Monday, 26 June 2017

Generics News

  • Cipla appoints Subhanu Saxena as CEO

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 23 Nov, 2012

    Mumbai: Indian generic pharmaceuticals company Cipla appointed Mr Subhanu Saxena as its chief executive officer. Mr Saxena comes to Cipla with experience of over 25 years, having worked wit...Read more

  • Cipla divests its stake from a Chinese firm

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2014

    Singapore: Indian pharma major, Cipla recently announced that the company's wholly owned subsidiary Meditab holdings entered into a definitive agreement to sell its entire 48.22 per cent st...Read more

  • Lupin, LG to launch an anti-diabetes drug

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2014

    Singapore: Indian drug major Lupin has inked a marketing pact with South Korea's LG Life Sciences to launch its anti-diabetes drug in India. As per the strategic distribution pact inked b...Read more

  • GSK to appoint RBS exec as new chairman

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 11 Aug, 2014

    Singapore: British drug maker GlaxoSmithKline is in advanced talks to recruit Sir Philip Hampton, chairman of Royal Bank of Scotland, as the next chairman. According to Sky News report, Sir...Read more

  • Cipla's HIV drug gets tentative nod from FDA

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 27 Feb, 2014

    Singapore: India based generic drug maker Cipla has recieved FDA tentative approval for a generic formulation of emtricitabine and tenofovir disoproxil fumarate tablets, 200 mg/300 mg. The...Read more

  • Dr. Reddy's Azacitidine for injection gets FDA nod

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013

    Singapore: The US FDA has granted approval for the launch of Dr. Reddy's Laboratories's cancer drug Azacitidine for injection. This generic version of Vidaza is used in the treatment of mye...Read more

  • Aurobindo aims for $2 bn revenues by FY15

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2014

    Singapore: India-based Aurobindo Pharma eyes on globalization and innovation to achieve a turnover of $2 billion in the current fiscal year. With 45 files under review with the USFDA, the ...Read more

  • Alvogen acquires Korea's Dream Pharma

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2014

    Singapore: The birth of one of the largest generic pharmaceutical companies in South Korea just came about when Alvogen decided to acquire Korea's Dream Pharma. The deal, closed in cash, in...Read more

  • Aurobindo gets FDA nod for anti-depression generic

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2012

    Singapore: India's Aurobindo Pharma received final approval from the US FDA to manufacture and market Escitalopram Oxalate tablets 5mg, 10mg and 20mg (ANDA 090432), which was earlier tentat...Read more

  • Canada quarantines APIs by India firm

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2015

    Singapore: Canada has quarantined the health products made with active pharmaceutical ingredients (APIs) from India's Sri Krishna Pharmaceuticals due to data integrity concerns. Health Can...Read more

  • Fosun Pharma listed in CCTV Financial 50 Index Sample Stock

    Generics |  Company results | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2013

    Singapore: Shanghai Fosun Pharmaceutical has been listed in CCTV Financial 50 Index Sample Stock, an index created by Shenzhen Securities Information and CCTV Finance Channel with the index...Read more

  • First generic of diabetes drug Actos approved

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 20 Aug, 2012

    Singapore: The US FDA has approved world's first generic version of Actos (pioglitazone hydrochloride) tablets. US-based pharma company Mylan Pharmaceuticals, received FDA approval for 15 m...Read more

  • Ranbaxy redesigns strategy to meet regulations

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2012

    The year 2011 was a year of capturing potential markets and achieving new milestones. Ranbaxy Laboratories became the first pharmaceutical company of Indian origin to cross a figure of $1.5...Read more

  • Interpol seized $41 mn fake drugs to be sold online

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2013

    Singapore: Interpol's sixth and the biggest annual worldwide crackdown, Pangea VI has ended in seizing of $41 million worth of illegal pharmaceuticals that were being sold online. The worl...Read more

  • India, China to produce generic of Gilead's TAF

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 04 Aug, 2014

    Singapore: Gilead have allowed generic manufacturers in India and China to produce generic versions of its HBV and HIV drug, tenofovir alafenamide (TAF). The company is in agreement with t...Read more

  • Indian formulation industry to grow by 10-12%

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2013

    Singapore: The Indian pharmaceutical industry is estimated to continue to experience strong growth in the near-term although there would be some moderation in the growth trajectory, a repor...Read more

  • Dr. Reddy's hires its HR global head from IBM

    Generics |  Influencers | By BioSpectrum Bureau | 0 Comment | 13 Aug, 2013

    Singapore: India's pharmaceutical firm Dr. Reddy's has appointed Dr. Sripada Chandrasekhar as the president and global head of human resources. He will also be a member of Dr. Reddy's Manag...Read more

  • Huahai gets China FDA nod to make HIV/AIDS generic

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 25 Sep, 2013

    Singapore: China-based Zhejiang Huahai Pharma received approval from the China FDA to produce efavirenz. Huahai is the first Chinese drugmaker to receive approval to make the drug. The dru...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls